|
gptkbp:instanceOf
|
phytocannabinoid
|
|
gptkbp:affects
|
gptkb:endocannabinoid_system
|
|
gptkbp:alsoKnownAs
|
gptkb:CBD
|
|
gptkbp:ATCCode
|
N03AX24
|
|
gptkbp:boilingPoint
|
160–180 °C
|
|
gptkbp:CASNumber
|
13956-29-1
|
|
gptkbp:chemicalFormula
|
C21H30O2
|
|
gptkbp:discoveredBy
|
gptkb:Roger_Adams
|
|
gptkbp:discoveredIn
|
1940
|
|
gptkbp:eliminationHalfLife
|
18–32 hours
|
|
gptkbp:foundIn
|
hemp
Cannabis
|
|
gptkbp:hasApprovedDrug
|
gptkb:Epidiolex
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Cannabidiol
|
|
gptkbp:interactsWith
|
gptkb:5-HT1A_receptor
gptkb:TRPV1_receptor
PPARγ receptor
|
|
gptkbp:isomerOf
|
gptkb:tetrahydrocannabinol
|
|
gptkbp:IUPACName
|
2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol
|
|
gptkbp:legalStatus
|
varies by country
|
|
gptkbp:marketedAs
|
gptkb:drug
cosmetic product
dietary supplement
|
|
gptkbp:meltingPoint
|
66 °C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
314.47 g/mol
|
|
gptkbp:notPsychoactive
|
true
|
|
gptkbp:producedBy
|
glandular trichomes of cannabis plant
|
|
gptkbp:psychoactive
|
no
|
|
gptkbp:PubChem_CID
|
557239
644019
ChEMBL180
|
|
gptkbp:regulates
|
CB1 receptor (indirectly)
CB2 receptor (indirectly)
|
|
gptkbp:routeOfAdministration
|
oral
topical
inhalation
sublingual
|
|
gptkbp:sideEffect
|
diarrhea
fatigue
drowsiness
dry mouth
reduced appetite
|
|
gptkbp:solubility
|
lipid-soluble
|
|
gptkbp:UNII
|
19GBJ60SN5
|
|
gptkbp:usedFor
|
pain management
anti-inflammatory
epilepsy treatment
anxiety relief
|
|
gptkbp:bfsParent
|
gptkb:Marijuana
|
|
gptkbp:bfsLayer
|
7
|